CA2184826A1 - Dosage immunologique conjugue a une fluorescence directe et s'appliquant a l'activation plaquettaire - Google Patents

Dosage immunologique conjugue a une fluorescence directe et s'appliquant a l'activation plaquettaire

Info

Publication number
CA2184826A1
CA2184826A1 CA 2184826 CA2184826A CA2184826A1 CA 2184826 A1 CA2184826 A1 CA 2184826A1 CA 2184826 CA2184826 CA 2184826 CA 2184826 A CA2184826 A CA 2184826A CA 2184826 A1 CA2184826 A1 CA 2184826A1
Authority
CA
Canada
Prior art keywords
sample
platelets
samples
selectin
platelet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2184826
Other languages
English (en)
Inventor
Bruce A. Kottke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WATSON CLINIC FOUNDATION
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2184826A1 publication Critical patent/CA2184826A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/7056—Selectin superfamily, e.g. LAM-1, GlyCAM, ELAM-1, PADGEM
    • G01N2333/70564—Selectins, e.g. CD62

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

L'invention se rapporte à un procédé de mesure de l'étendue de l'activation plaquettaire qui consiste à déterminer par fluorimétrie in vitro l'étendue de l'expression de la sélectine P dans un échantillon de sang entier au moyen d'un échantillon de plaquettes activées au maximum, utilisé comme standard de référence.
CA 2184826 1994-10-25 1995-10-24 Dosage immunologique conjugue a une fluorescence directe et s'appliquant a l'activation plaquettaire Abandoned CA2184826A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US470,980 1990-01-26
US32847594A 1994-10-25 1994-10-25
US328,475 1994-10-25
US47098095A 1995-06-06 1995-06-06

Publications (1)

Publication Number Publication Date
CA2184826A1 true CA2184826A1 (fr) 1996-05-02

Family

ID=26986392

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2184826 Abandoned CA2184826A1 (fr) 1994-10-25 1995-10-24 Dosage immunologique conjugue a une fluorescence directe et s'appliquant a l'activation plaquettaire

Country Status (7)

Country Link
JP (1) JPH10512951A (fr)
AU (1) AU689346B2 (fr)
BR (1) BR9507579A (fr)
CA (1) CA2184826A1 (fr)
FI (1) FI963848A0 (fr)
NO (1) NO963780L (fr)
WO (1) WO1996012956A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0946877A1 (fr) * 1996-11-13 1999-10-06 Centocor, Inc. Dosages de p-selectine et procedes d'utilisation correspondants
GB2338236B (en) 1998-06-13 2003-04-09 Aea Technology Plc Microbiological cell processing
US6159443A (en) * 1999-04-29 2000-12-12 Vanderbilt University X-ray guided drug delivery
US7049140B1 (en) 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
JP2001131078A (ja) * 1999-11-09 2001-05-15 Iatron Lab Inc 新規活性固定化血小板及びその製造方法
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
US7306925B2 (en) 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
US6913932B2 (en) * 2002-08-23 2005-07-05 Beckman Coulter, Inc. Formaldehyde-ammonium salt complexes for the stabilization of blood cells
US20110250588A1 (en) * 2008-12-18 2011-10-13 Sysmex Corporation Method for detecting cancer cells in blood sample
DK3054936T5 (da) 2013-10-10 2024-03-18 Eastern Virginia Medical School 4-((2-hydroxy-3-methoxybenzyl)amino) benzensulfonamid derivater som 12-lipoxygenase inhibitorer
US10449261B2 (en) 2014-07-24 2019-10-22 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
FR3109999A1 (fr) * 2020-05-05 2021-11-12 Etablissement Français Du Sang Methode de detection de l’activation plaquettaire liee a l’inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783330A (en) * 1984-11-15 1988-11-08 New England Medical Center Hospitals, Inc. Monoclonal antibodies to activated platelets
US5030554A (en) * 1987-12-04 1991-07-09 Coulter Corporation Conservative whole blood sample preparation technique

Also Published As

Publication number Publication date
AU4016895A (en) 1996-05-15
FI963848A (fi) 1996-09-26
JPH10512951A (ja) 1998-12-08
NO963780L (no) 1997-08-25
MX9604205A (es) 1998-05-31
BR9507579A (pt) 1997-09-09
WO1996012956A1 (fr) 1996-05-02
AU689346B2 (en) 1998-03-26
FI963848A0 (fi) 1996-09-26
NO963780D0 (no) 1996-09-10

Similar Documents

Publication Publication Date Title
Michelson Flow cytometry: a clinical test of platelet function
Michelson et al. Evaluation of platelet function by flow cytometry
Centis et al. The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with β-thalassemia major
Konijnenberg et al. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules
US5385822A (en) Methods for detection and quantification of cell subsets within subpopulations of a mixed cell population
US5256538A (en) Detection of early platelet activation and prediagnosis of thrombotic events
CA2184826A1 (fr) Dosage immunologique conjugue a une fluorescence directe et s'appliquant a l'activation plaquettaire
Zeller et al. Influence of valproate monotherapy on platelet activation and hematologic values
US5529902A (en) Direct fluorescence-conjugated immunoassay for platelet activation
JP3115604B2 (ja) 患者の急性心筋梗塞症の検出
US5939276A (en) Flow cytometry assay for heparin-induced thrombocytopenia
Goodall Platelet activation during preparation and storage of concentrates: detection by flow cytometry
Jackson et al. Heterogeneity of fibrinogen receptor expression on platelets activated in normal plasma with ADP: analysis by flow cytometry
Gockerman et al. Detection of platelet isoantibodies by (3H) serotonin platelet release and its clinical application to the problem of platelet matching.
Joseph et al. Platelet activation and turnover in the primary antiphospholipid syndrome
Janes et al. ADP causes partial degranulation of platelets in the absence of aggregation
Tschöpe et al. Platelet analysis using flowcytometric procedures
Wun et al. Physiologic concentrations of arginine vasopressin activate human platelets in vitro
EP0386015A1 (fr) Analyse immunologique d'anticorps se liant aux plaquettes sanguines
Sbrana et al. Post‐reperfusion changes of monocyte function in coronary blood after extracorporeal circulation
Li et al. A whole‐blood flow cytometric assay for leukocyte CD11b expression using fluorescence signal triggering
Pearson et al. A rapid flow cytometric technique for the detection of platelet‐monocyte complexes, activated platelets and platelet‐derived microparticles
US8383410B2 (en) C4d/C4b standard for quantitative flow cytometry of humoral transplant rejection
Lindahl et al. Studies of the platelet fibrinogen receptor in Glanzmann patients and uremic patients
Dockter et al. Paroxysmal nocturnal hemoglobinuria erythrocytes are of two distinct types: Positive or negative for acetylcholinesterase

Legal Events

Date Code Title Description
FZDE Dead